Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Molecular Targeted Therapy
1.2 Key Market Segments
1.2.1 Molecular Targeted Therapy Segment by Type
1.2.2 Molecular Targeted Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Molecular Targeted Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Molecular Targeted Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Molecular Targeted Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Molecular Targeted Therapy Market Competitive Landscape
3.1 Global Molecular Targeted Therapy Sales by Manufacturers (2019-2025)
3.2 Global Molecular Targeted Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Molecular Targeted Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Molecular Targeted Therapy Sales Sites, Area Served, Product Type
3.6 Molecular Targeted Therapy Market Competitive Situation and Trends
3.6.1 Molecular Targeted Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Molecular Targeted Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Molecular Targeted Therapy Industry Chain Analysis
4.1 Molecular Targeted Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Molecular Targeted Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Molecular Targeted Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Targeted Therapy Sales Market Share by Type (2019-2025)
6.3 Global Molecular Targeted Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Molecular Targeted Therapy Price by Type (2019-2025)
7 Molecular Targeted Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Targeted Therapy Market Sales by Application (2019-2025)
7.3 Global Molecular Targeted Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Molecular Targeted Therapy Sales Growth Rate by Application (2019-2025)
8 Molecular Targeted Therapy Market Consumption by Region
8.1 Global Molecular Targeted Therapy Sales by Region
8.1.1 Global Molecular Targeted Therapy Sales by Region
8.1.2 Global Molecular Targeted Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Molecular Targeted Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Molecular Targeted Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Molecular Targeted Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Molecular Targeted Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Molecular Targeted Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Molecular Targeted Therapy Market Production by Region
9.1 Global Production of Molecular Targeted Therapy by Region (2019-2025)
9.2 Global Molecular Targeted Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Molecular Targeted Therapy Production
9.4.1 North America Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.4.2 North America Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Molecular Targeted Therapy Production
9.5.1 Europe Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Molecular Targeted Therapy Production (2019-2025)
9.6.1 Japan Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Molecular Targeted Therapy Production (2019-2025)
9.7.1 China Molecular Targeted Therapy Production Growth Rate (2019-2025)
9.7.2 China Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Phoenix Molecular Designs
10.1.1 Phoenix Molecular Designs Molecular Targeted Therapy Basic Information
10.1.2 Phoenix Molecular Designs Molecular Targeted Therapy Product Overview
10.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Product Market Performance
10.1.4 Phoenix Molecular Designs Business Overview
10.1.5 Phoenix Molecular Designs Molecular Targeted Therapy SWOT Analysis
10.1.6 Phoenix Molecular Designs Recent Developments
10.2 Prelude Therapeutics
10.2.1 Prelude Therapeutics Molecular Targeted Therapy Basic Information
10.2.2 Prelude Therapeutics Molecular Targeted Therapy Product Overview
10.2.3 Prelude Therapeutics Molecular Targeted Therapy Product Market Performance
10.2.4 Prelude Therapeutics Business Overview
10.2.5 Prelude Therapeutics Molecular Targeted Therapy SWOT Analysis
10.2.6 Prelude Therapeutics Recent Developments
10.3 Tempus
10.3.1 Tempus Molecular Targeted Therapy Basic Information
10.3.2 Tempus Molecular Targeted Therapy Product Overview
10.3.3 Tempus Molecular Targeted Therapy Product Market Performance
10.3.4 Tempus Molecular Targeted Therapy SWOT Analysis
10.3.5 Tempus Business Overview
10.3.6 Tempus Recent Developments
10.4 Bracco
10.4.1 Bracco Molecular Targeted Therapy Basic Information
10.4.2 Bracco Molecular Targeted Therapy Product Overview
10.4.3 Bracco Molecular Targeted Therapy Product Market Performance
10.4.4 Bracco Business Overview
10.4.5 Bracco Recent Developments
10.5 iOmx Therapeutics
10.5.1 iOmx Therapeutics Molecular Targeted Therapy Basic Information
10.5.2 iOmx Therapeutics Molecular Targeted Therapy Product Overview
10.5.3 iOmx Therapeutics Molecular Targeted Therapy Product Market Performance
10.5.4 iOmx Therapeutics Business Overview
10.5.5 iOmx Therapeutics Recent Developments
10.6 OncoDNA
10.6.1 OncoDNA Molecular Targeted Therapy Basic Information
10.6.2 OncoDNA Molecular Targeted Therapy Product Overview
10.6.3 OncoDNA Molecular Targeted Therapy Product Market Performance
10.6.4 OncoDNA Business Overview
10.6.5 OncoDNA Recent Developments
10.7 Sapience Therapeutics
10.7.1 Sapience Therapeutics Molecular Targeted Therapy Basic Information
10.7.2 Sapience Therapeutics Molecular Targeted Therapy Product Overview
10.7.3 Sapience Therapeutics Molecular Targeted Therapy Product Market Performance
10.7.4 Sapience Therapeutics Business Overview
10.7.5 Sapience Therapeutics Recent Developments
10.8 Caris Life Sciences
10.8.1 Caris Life Sciences Molecular Targeted Therapy Basic Information
10.8.2 Caris Life Sciences Molecular Targeted Therapy Product Overview
10.8.3 Caris Life Sciences Molecular Targeted Therapy Product Market Performance
10.8.4 Caris Life Sciences Business Overview
10.8.5 Caris Life Sciences Recent Developments
10.9 Hera Biolabs
10.9.1 Hera Biolabs Molecular Targeted Therapy Basic Information
10.9.2 Hera Biolabs Molecular Targeted Therapy Product Overview
10.9.3 Hera Biolabs Molecular Targeted Therapy Product Market Performance
10.9.4 Hera Biolabs Business Overview
10.9.5 Hera Biolabs Recent Developments
10.10 CV6 Therapeutics
10.10.1 CV6 Therapeutics Molecular Targeted Therapy Basic Information
10.10.2 CV6 Therapeutics Molecular Targeted Therapy Product Overview
10.10.3 CV6 Therapeutics Molecular Targeted Therapy Product Market Performance
10.10.4 CV6 Therapeutics Business Overview
10.10.5 CV6 Therapeutics Recent Developments
10.11 Carrick Therapeutics
10.11.1 Carrick Therapeutics Molecular Targeted Therapy Basic Information
10.11.2 Carrick Therapeutics Molecular Targeted Therapy Product Overview
10.11.3 Carrick Therapeutics Molecular Targeted Therapy Product Market Performance
10.11.4 Carrick Therapeutics Business Overview
10.11.5 Carrick Therapeutics Recent Developments
10.12 Foundation Medicine
10.12.1 Foundation Medicine Molecular Targeted Therapy Basic Information
10.12.2 Foundation Medicine Molecular Targeted Therapy Product Overview
10.12.3 Foundation Medicine Molecular Targeted Therapy Product Market Performance
10.12.4 Foundation Medicine Business Overview
10.12.5 Foundation Medicine Recent Developments
10.13 Cybrexa Therapeutics
10.13.1 Cybrexa Therapeutics Molecular Targeted Therapy Basic Information
10.13.2 Cybrexa Therapeutics Molecular Targeted Therapy Product Overview
10.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Product Market Performance
10.13.4 Cybrexa Therapeutics Business Overview
10.13.5 Cybrexa Therapeutics Recent Developments
11 Molecular Targeted Therapy Market Forecast by Region
11.1 Global Molecular Targeted Therapy Market Size Forecast
11.2 Global Molecular Targeted Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Molecular Targeted Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Molecular Targeted Therapy Market Size Forecast by Region
11.2.4 South America Molecular Targeted Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Molecular Targeted Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Molecular Targeted Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Molecular Targeted Therapy by Type (2025-2032)
12.1.2 Global Molecular Targeted Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Molecular Targeted Therapy by Type (2025-2032)
12.2 Global Molecular Targeted Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Molecular Targeted Therapy Sales (K Units) Forecast by Application
12.2.2 Global Molecular Targeted Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
